Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model.

about

Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model.

Item

http://www.wikidata.org/entity/Q55042761

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Combination Treatment of C16 P ...... tica in an Experimental Model.

@en

Combination Treatment of C16 P ...... tica in an Experimental Model.

@nl

type

Item

label

Combination Treatment of C16 P ...... tica in an Experimental Model.

@en

Combination Treatment of C16 P ...... tica in an Experimental Model.

@nl

prefLabel

Combination Treatment of C16 P ...... tica in an Experimental Model.

@en

Combination Treatment of C16 P ...... tica in an Experimental Model.

@nl

P1476

Combination Treatment of C16 P ...... ptica in an Experimental Model

@en

P2093

Beibei Wang

http://www.w3.org/2001/XMLSchema#string

Hong Jiang

http://www.w3.org/2001/XMLSchema#string

Kewei Tian

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Neuromyelitis optica pathogenesis and aquaporin 4

Molecular pathogenesis of neuromyelitis optica

Astrocyte-endothelial interactions at the blood-brain barrier

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

Rescuing vasculature with intravenous angiopoietin-1 and alpha v beta 3 integrin peptide is protective after spinal cord injury.

Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.

Angiopoietin-1 peptide QHREDGS promotes osteoblast differentiation, bone matrix deposition and mineralization on biomedical materials.

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model

P304

4187347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/4187347

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Shu Han

P577

2018-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29670463

http://www.w3.org/2001/XMLSchema#string

P932

5835265

http://www.w3.org/2001/XMLSchema#string